Bristol-Myers Squibb Company
PYRIMIDINE CARBOXAMIDES AS GSK-3 INHIBITORS

Abstract:

The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds to treat disorders associated with GSK-3. ##STR00001##